This compound is a pharmaceutical intermediate used in the manufacturing of active pharmaceutical ingredients. It features an ester group and two ether linkages, contributing to its moderate lipophilicity and single hydrogen-bond donor.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 87129-32-6
Ethyl 2-(4-hydroxyphenoxy)propionate
Pharmaceutical intermediate for herbicide synthesis
(4-Chloro-3-cyanophenyl)boronic acid
Pharmaceutical intermediate for synthesis
3-((2S,5S)-5-((3R,5R)-5-Methyl-3-((methylsulfonyl)oxy)-6-(((trifluoromethyl)sulfonyl)oxy)hept-6-en-1-yl)-4-methylenetetrahydrofuran-2-yl)propyl pivalate
pharmaceutical intermediate
(1R,3S,5R,6R,7S,11R,14S,15S,16S,17R,18S,19S,20Z,22R,25S,28S,31S,33R)-5-[(2S)-2,3-bis[[tert-butyl(dimethyl)silyl]oxy]propyl]-16,17,19-tris[[tert-butyl(dimethyl)silyl]oxy]-22-hydroxy-6-methoxy-33-methyl-27,34-dimethylidene-4,35,36,37,38-pentaoxahexacyclo[29.3.1.111,15.114,18.125,28.03,7]octatriacont-20-en-9-one
pharmaceutical intermediate for complex polyether synthesis
1-Cinnamylpiperazine
Pharmaceutical intermediate for flunarizine
butyl (2R)-2-(4-hydroxyphenoxy)propanoate
MPNXVFDGEQKYAY-SNVBAGLBSA-N
CCCCOC(=O)[C@@H](C)OC1=CC=C(C=C1)O
—